Profile

Dr. Kamal Kant Kohli

Designation: Senior Consultant

Organization: Medical Dialogues

Specialisation: Pulmonology

City: Delhi

Description: Dr. Kamal Kant Kohli is a renowned pulmonologist with over 20 years of experience in treating respiratory conditions including asthma, COPD, and lung infections. He regularly contributes to medical literature and patient awareness initiatives.

✔ Verified

U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or Levocetirizine Use

Dr. Kamal Kant Koh... 16 June 2025 12:30 PM

The U.S. Food and Drug Administration (FDA) has recently issued a warning that patients stopping the oral antihistamines - cetirizine or...

U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or Levocetirizine Use

Dr. Kamal Kant Koh... 16 June 2025 12:30 PM

The U.S. Food and Drug Administration (FDA) has recently issued a warning that patients stopping the oral antihistamines - cetirizine or...

U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or Levocetirizine Use

Dr. Kamal Kant Koh... 16 June 2025 12:30 PM

The U.S. Food and Drug Administration (FDA) has recently issued a warning that patients stopping the oral antihistamines - cetirizine or...

Medical Dialogues

Dr. Kamal Kant Kohli

Related Articles

U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or Levocetirizine Use

U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or Levocetirizine Use

U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or Levocetirizine Use

Editorial